115 related articles for article (PubMed ID: 38042685)
1. Corrigendum to "CircIQGAP1 regulates RCAN1 and RCAN2 through the mechanism of ceRNA and promotes the growth of malignant glioma" [Pharmacol. Res. 197 (2023) 106979].
Huang X; Wang Z; Song M; Huan H; Cai Z; Wu B; Shen J; Zhou YL; Shi J
Pharmacol Res; 2024 Jan; 199():107021. PubMed ID: 38042685
[No Abstract] [Full Text] [Related]
2. CircIQGAP1 regulates RCAN1 and RCAN2 through the mechanism of ceRNA and promotes the growth of malignant glioma.
Huang X; Wang Z; Song M; Huan H; Cai Z; Wu B; Shen J; Zhou YL; Shi J
Pharmacol Res; 2023 Nov; 197():106979. PubMed ID: 37918583
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of members of the RCAN family of calcineurin regulators suggests selective functions for these proteins in the brain.
Porta S; Martí E; de la Luna S; Arbonés ML
Eur J Neurosci; 2007 Sep; 26(5):1213-26. PubMed ID: 17767500
[TBL] [Abstract][Full Text] [Related]
4. The regulator of calcineurin 1 (RCAN1) inhibits nuclear factor kappaB signaling pathway and suppresses human malignant glioma cells growth.
Chen X; Hu Y; Wang S; Sun X
Oncotarget; 2017 Feb; 8(7):12003-12012. PubMed ID: 28061453
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum to "Dihydroartemisin inhibits glioma invasiveness via a ROS to P53 to β-catenin signaling" [Pharmacol. Res. 119 (2017) 72-88].
Que Z; Wang P; Hu Y; Xue Y; Liu X; Qu C; Ma J; Liu Y
Pharmacol Res; 2021 Nov; 173():105908. PubMed ID: 34583877
[No Abstract] [Full Text] [Related]
6. Corrigendum to "Blood exosome sensing via neuronal insulin-like growth factor-1 regulates autism-related phenotypes" [Pharmacol. Res. 197 (2023) 106965].
Chen L; Xiong XY; Yao TT; Gui LN; Luo F; Du Y; Cheng Y
Pharmacol Res; 2024 Jan; 199():107014. PubMed ID: 38040600
[No Abstract] [Full Text] [Related]
7. Corrigendum to "A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation" [Pharmacol. Res. 194 (2023) 106851].
Gao F; Yao Q; Zhu J; Chen W; Feng X; Feng B; Wu J; Pacak K; Rosenblum J; Yu J; Zhuang Z; Cao H; Li L
Pharmacol Res; 2024 Apr; 202():107135. PubMed ID: 38461139
[No Abstract] [Full Text] [Related]
8. Mice lacking the calcineurin inhibitor Rcan2 have an isolated defect of osteoblast function.
Bassett JH; Logan JG; Boyde A; Cheung MS; Evans H; Croucher P; Sun XY; Xu S; Murata Y; Williams GR
Endocrinology; 2012 Jul; 153(7):3537-48. PubMed ID: 22593270
[TBL] [Abstract][Full Text] [Related]
9. A disputed evidence on obesity: comparison of the effects of Rcan2(-/-) and Rps6kb1(-/-) mutations on growth and body weight in C57BL/6J mice.
Zhao J; Li SW; Gong QQ; Ding LC; Jin YC; Zhang J; Gao JG; Sun XY
J Zhejiang Univ Sci B; 2016 Sep; 17(9):657-71. PubMed ID: 27604858
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum to "RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7" [Biochem. Pharmacol. 180 (2020) 114118].
Liang H; Wang Q; Wang D; Zheng H; Kalvakolanu DV; Lu H; Wen N; Chen X; Xu L; Ren J; Guo B; Zhang L
Biochem Pharmacol; 2020 Dec; 182():114223. PubMed ID: 33039815
[No Abstract] [Full Text] [Related]
11. Rcan2 and estradiol independently regulate body weight in female mice.
Ding LC; Gong QQ; Li SW; Fu XL; Jin YC; Zhang J; Gao JG; Sun XY
Oncotarget; 2017 Jul; 8(29):48098-48109. PubMed ID: 28624805
[TBL] [Abstract][Full Text] [Related]
12. mir-182-5p Regulates Cell Growth of Liver Cancer via Targeting RCAN1.
Zheng J; Wu D; Wang L; Qu F; Cheng D; Liu X
Gastroenterol Res Pract; 2021; 2021():6691305. PubMed ID: 33959160
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum to "Dasatinib ameliorates chronic pancreatitis induced by caerulein via anti-fibrotic and anti-inflammatory mechanism" [Pharmacol Res. 147 (2019) 104357].
Zeng XP; Wang LJ; Guo HL; He L; Bi YW; Xu ZL; Li ZS; Hu LH
Pharmacol Res; 2020 Jun; 156():104788. PubMed ID: 32402600
[No Abstract] [Full Text] [Related]
14. Construction and comprehensive analysis of a competitive endogenous RNA network to reveal potential biomarkers for the malignant differentiation of glioma.
Li X; Zhang J; Zhang M; Qi X; Wang S; Teng J
Medicine (Baltimore); 2021 Oct; 100(39):e27248. PubMed ID: 34596120
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of RCAN2 production in gastric carcinoma.
Hattori Y; Sentani K; Shinmei S; Oo HZ; Hattori T; Imai T; Sekino Y; Sakamoto N; Oue N; Niitsu H; Hinoi T; Ohdan H; Yasui W
Histopathology; 2019 Feb; 74(3):430-442. PubMed ID: 30307052
[TBL] [Abstract][Full Text] [Related]
16. p38α MAP kinase phosphorylates RCAN1 and regulates its interaction with calcineurin.
Ma L; Tang H; Ren Y; Deng H; Wu J; Wang Z
Sci China Life Sci; 2012 Jul; 55(7):559-66. PubMed ID: 22864830
[TBL] [Abstract][Full Text] [Related]
17. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.
Deng R; Huang JH; Wang Y; Zhou LH; Wang ZF; Hu BX; Chen YH; Yang D; Mai J; Li ZL; Zhang HL; Huang Y; Peng XD; Feng GK; Zhu XF; Tang J
Mol Cancer; 2020 Aug; 19(1):122. PubMed ID: 32771023
[TBL] [Abstract][Full Text] [Related]
18. Elevated Serum Regulator of Calcineurin 2 is Associated With an Increased Risk of Non-Alcoholic Fatty Liver Disease.
Fang X; Wang H; Tan X; Ye T; Xu Y; Fan J
Front Pharmacol; 2022; 13():840764. PubMed ID: 35370729
[No Abstract] [Full Text] [Related]
19. Association Between Circulating Regulator of Calcineurin 2 Concentrations With Overweight and Obesity.
Wang H; Fang X; Ren Q; Zeng Y; Tan X; Ye T; Fan J; Xu Y
Front Endocrinol (Lausanne); 2022; 13():857841. PubMed ID: 35733783
[TBL] [Abstract][Full Text] [Related]
20. Regulator of calcineurin 1 deletion attenuates mitochondrial dysfunction and apoptosis in acute kidney injury through JNK/Mff signaling pathway.
Xiao JJ; Liu Q; Li Y; Peng FF; Wang S; Zhang Z; Liu H; Yu H; Tao S; Zhang BF
Cell Death Dis; 2022 Sep; 13(9):774. PubMed ID: 36071051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
